Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Periodicals
Amazon exec says multiple companies signed to telehealth service, CNBC reports » 15:18
06/09/21
06/09
15:18
06/09/21
15:18
AMZN

Amazon.com

$3,290.00 /

+23.81 (+0.73%)

, TDOC

Teladoc

$153.25 /

+0.31 (+0.20%)

, AMWL

Amwell

$13.90 /

-0.35 (-2.46%)

, ONEM

1Life Healthcare

$34.71 /

-0.08 (-0.23%)

Amazon (AMZN) executive…

Amazon (AMZN) executive Babak Parviz, a vice president working on Amazon Care, said at the Wall Street Journal's Tech Health event that the company has "had quite a bit of interest from other companies in using this service," and added that Amazon plans to announce which companies have signed on to use the service later this summer, according to CNBC's Annie Palmer. Other companies in the virtual healthcare space include Amwell (AMWL), 1Life Healthcare (ONEM) and Teladoc Health (TDOC). Reference Link

ShowHide Related Items >><<
TDOC Teladoc
$153.25 /

+0.31 (+0.20%)

ONEM 1Life Healthcare
$34.71 /

-0.08 (-0.23%)

AMZN Amazon.com
$3,290.00 /

+23.81 (+0.73%)

AMWL Amwell
$13.90 /

-0.35 (-2.46%)

AMZN Amazon.com
$3,290.00 /

+23.81 (+0.73%)

06/08/21 Piper Sandler
New Amazon offering targets Hims & Hers and others, says Piper Sandler
06/08/21 UBS
Snowflake price target raised to $300 from $275 at UBS
06/07/21 Loop Capital
Best Buy prices remain 'very competitive' to Amazon's, says Loop Capital
06/07/21 Roth Capital
iPower initiated with a Buy at Roth Capital
TDOC Teladoc
$153.25 /

+0.31 (+0.20%)

05/28/21 Baird
Baird starts Teladoc with a Neutral, sees balanced risk/reward
05/27/21 Baird
Teladoc initiated with a Neutral at Baird
05/10/21 Truist
Teladoc price target lowered to $206 from $275 at Truist
05/04/21 Piper Sandler
Teladoc closed down 5% on three year old 'news,' says Piper Sandler
AMWL Amwell
$13.90 /

-0.35 (-2.46%)

05/17/21 Guggenheim
Amwell upgraded to Buy from Neutral at Guggenheim
05/13/21 Piper Sandler
Amwell price target lowered to $20 from $30 at Piper Sandler
05/03/21 Cantor Fitzgerald
Teladoc competitive loss a gain for Amwell, says Cantor Fitzgerald
ONEM 1Life Healthcare
$34.71 /

-0.08 (-0.23%)

06/09/21 Deutsche Bank
1Life Healthcare price target lowered to $39 from $50 at Deutsche Bank
06/08/21 Citi
Citi 'even more positive' on 1Life acquisition after management call
06/07/21 Piper Sandler
1Life Healthcare price target raised to $55.50 from $48.00 at Piper Sandler
05/28/21 Baird
Baird starts 'uniquely well-positioned' 1Life Healthcare with an Outperform
TDOC Teladoc
$153.25 /

+0.31 (+0.20%)

ONEM 1Life Healthcare
$34.71 /

-0.08 (-0.23%)

AMZN Amazon.com
$3,290.00 /

+23.81 (+0.73%)

AMWL Amwell
$13.90 /

-0.35 (-2.46%)

  • 15
    Jan
  • 23
    Nov
  • 17
    Sep
  • 25
    Jun
TDOC Teladoc
$153.25 /

+0.31 (+0.20%)

ONEM 1Life Healthcare
$34.71 /

-0.08 (-0.23%)

AMZN Amazon.com
$3,290.00 /

+23.81 (+0.73%)

TDOC Teladoc
$153.25 /

+0.31 (+0.20%)

ONEM 1Life Healthcare
$34.71 /

-0.08 (-0.23%)

AMZN Amazon.com
$3,290.00 /

+23.81 (+0.73%)

AMWL Amwell
$13.90 /

-0.35 (-2.46%)

TDOC Teladoc
$153.25 /

+0.31 (+0.20%)

AMZN Amazon.com
$3,290.00 /

+23.81 (+0.73%)

AMWL Amwell
$13.90 /

-0.35 (-2.46%)

Recommendations
1Life Healthcare price target lowered to $39 from $50 at Deutsche Bank » 06:50
06/09/21
06/09
06:50
06/09/21
06:50
ONEM

1Life Healthcare

$34.79 /

-0.16 (-0.46%)

Deutsche Bank analyst…

Deutsche Bank analyst George Hill lowered the firm's price target on 1Life Healthcare to $39 from $50 and keeps a Buy rating on the shares after the company announced a deal to acquire Iora Health in an all stock transaction, valuing the company at $2.1B.

ShowHide Related Items >><<
ONEM 1Life Healthcare
$34.79 /

-0.16 (-0.46%)

ONEM 1Life Healthcare
$34.79 /

-0.16 (-0.46%)

06/08/21 Citi
Citi 'even more positive' on 1Life acquisition after management call
06/07/21 Piper Sandler
1Life Healthcare price target raised to $55.50 from $48.00 at Piper Sandler
05/28/21 Baird
Baird starts 'uniquely well-positioned' 1Life Healthcare with an Outperform
05/27/21 Baird
1Life Healthcare initiated with an Outperform at Baird
ONEM 1Life Healthcare
$34.79 /

-0.16 (-0.46%)

  • 23
    Nov
  • 25
    Jun
ONEM 1Life Healthcare
$34.79 /

-0.16 (-0.46%)

ONEM 1Life Healthcare
$34.79 /

-0.16 (-0.46%)

Hot Stocks
Cathie Wood's ARK Investment bought 429.6K shares of 1Life Healthcare on Monday  06:32
06/08/21
06/08
06:32
06/08/21
06:32
ONEM

1Life Healthcare

$34.96 /

-0.67 (-1.88%)

 
ShowHide Related Items >><<
ONEM 1Life Healthcare
$34.96 /

-0.67 (-1.88%)

ONEM 1Life Healthcare
$34.96 /

-0.67 (-1.88%)

06/08/21 Citi
Citi 'even more positive' on 1Life acquisition after management call
06/07/21 Piper Sandler
1Life Healthcare price target raised to $55.50 from $48.00 at Piper Sandler
05/28/21 Baird
Baird starts 'uniquely well-positioned' 1Life Healthcare with an Outperform
05/27/21 Baird
1Life Healthcare initiated with an Outperform at Baird
ONEM 1Life Healthcare
$34.96 /

-0.67 (-1.88%)

  • 23
    Nov
  • 25
    Jun
ONEM 1Life Healthcare
$34.96 /

-0.67 (-1.88%)

ONEM 1Life Healthcare
$34.96 /

-0.67 (-1.88%)

Recommendations
Citi 'even more positive' on 1Life acquisition after management call » 06:28
06/08/21
06/08
06:28
06/08/21
06:28
ONEM

1Life Healthcare

$34.96 /

-0.67 (-1.88%)

Citi analyst Daniel…

Citi analyst Daniel Grosslight is "even more positive" on 1Life Healthcare's acquisition of Iora after speaking with management. He's "most bullish" on 1Life's ability to capture the economics of its clinical cost savings in the "large and lucrative" Medicare market. He keeps a Buy rating on the shares with a $55 price target.

ShowHide Related Items >><<
ONEM 1Life Healthcare
$34.96 /

-0.67 (-1.88%)

ONEM 1Life Healthcare
$34.96 /

-0.67 (-1.88%)

06/07/21 Piper Sandler
1Life Healthcare price target raised to $55.50 from $48.00 at Piper Sandler
05/28/21 Baird
Baird starts 'uniquely well-positioned' 1Life Healthcare with an Outperform
05/27/21 Baird
1Life Healthcare initiated with an Outperform at Baird
05/21/21
Fly Intel: Top five analyst initiations
ONEM 1Life Healthcare
$34.96 /

-0.67 (-1.88%)

  • 23
    Nov
  • 25
    Jun
ONEM 1Life Healthcare
$34.96 /

-0.67 (-1.88%)

ONEM 1Life Healthcare
$34.96 /

-0.67 (-1.88%)

Recommendations
1Life Healthcare price target raised to $55.50 from $48.00 at Piper Sandler » 11:31
06/07/21
06/07
11:31
06/07/21
11:31
ONEM

1Life Healthcare

$35.52 /

-0.11 (-0.31%)

Piper Sandler analyst…

Piper Sandler analyst Sean Wieland raised the firm's price target on 1Life Healthcare to $55.50 from $48.00 and keeps an Overweight rating on the shares. 1Life on Monday announced plans to buy Iora Health for $2.1B in an all-stock transaction, and Wieland tells investors in a research note that with Iora, 1Life will have a physical presence in 28 markets and address an estimated $870B annual revenue opportunity.

ShowHide Related Items >><<
ONEM 1Life Healthcare
$35.52 /

-0.11 (-0.31%)

ONEM 1Life Healthcare
$35.52 /

-0.11 (-0.31%)

05/28/21 Baird
Baird starts 'uniquely well-positioned' 1Life Healthcare with an Outperform
05/27/21 Baird
1Life Healthcare initiated with an Outperform at Baird
05/21/21
Fly Intel: Top five analyst initiations
05/21/21 KeyBanc
1Life Healthcare initiated with an Overweight at KeyBanc
ONEM 1Life Healthcare
$35.52 /

-0.11 (-0.31%)

  • 23
    Nov
  • 25
    Jun
ONEM 1Life Healthcare
$35.52 /

-0.11 (-0.31%)

ONEM 1Life Healthcare
$35.52 /

-0.11 (-0.31%)

Hot Stocks
1Life Healthcare to acquire Iora Health in $2.1B all-stock transaction » 07:45
06/07/21
06/07
07:45
06/07/21
07:45
ONEM

1Life Healthcare

$35.58 /

-0.72 (-1.98%)

1Life Healthcare …

1Life Healthcare announced it has entered into a definitive agreement to acquire Iora Health, a human-centric, value-based primary care group with built-for-purpose technology focused on serving Medicare populations, in an all-stock transaction valued at approximately $2.1 billion. One Medical and Iora Health are aligned in their missions, models, and cultures to transform healthcare for key stakeholders -- Consumers, Employers and Payers, Providers, and Health Networks. Together, the two companies can further accelerate and build upon their impacts for these stakeholders, while simultaneously expanding their models in existing markets, entering new markets, serving new populations, expanding full-risk models, and leveraging their purpose-built technologies for increased growth and scale. Strategic and financial benefits of the transaction include: Creates a premier national member-based, technology-powered primary care platform to deliver better health, better care, and lower costs across Commercial and Medicare populations; Positions One Medical with Iora Health to advance the health of members across every stage of life; Extends One Medical's platform to deliver multi-modal care with 24/7 national digital health and in-person care across a combined 28 markets and beyond; Expands potential market opportunity to $870 billion across Commercial and Medicare segments, including the new Medicare Direct Contracting program; Enhances One Medical's risk-taking capabilities and extends One Medical into full-risk Medicare reimbursement models; Amplifies the power of purpose-built technologies to deliver premier member experiences, population health, provider support, and value-based care across every stage of life; Accelerates the expansion of two high-growth organizations, with complementary cultures and models serving as a premier place to practice modernized healthcare; and, Offers an opportunity to create significant value, with an expected $350+ million in annual revenue synergies by 2025, ~$30 million in annual net cost synergies by 2025, and with ~$30 million in cumulative capex savings through 2025. A designee of Iora Health will join the One Medical Board and Rushika Fernandopulle will become One Medical's Chief Innovation Officer. Under the terms of the agreement, Iora Health shareholders will receive 56.1 million shares of One Medical common stock. Based on the closing share price of One Medical's common stock of $35.59 on June 4th, 2021, the total transaction is valued at approximately $2.1 billion. Upon completion of the transaction, Iora Health shareholders are expected to own approximately 26.75% of the combined company. The transaction is expected to close in late Q3 or Q4 of 2021 and is subject to customary closing conditions, including approval by One Medical and Iora Health stockholders and receipt of regulatory approval.

ShowHide Related Items >><<
ONEM 1Life Healthcare
$35.58 /

-0.72 (-1.98%)

ONEM 1Life Healthcare
$35.58 /

-0.72 (-1.98%)

05/28/21 Baird
Baird starts 'uniquely well-positioned' 1Life Healthcare with an Outperform
05/27/21 Baird
1Life Healthcare initiated with an Outperform at Baird
05/21/21
Fly Intel: Top five analyst initiations
05/21/21 KeyBanc
1Life Healthcare initiated with an Overweight at KeyBanc
ONEM 1Life Healthcare
$35.58 /

-0.72 (-1.98%)

  • 23
    Nov
  • 25
    Jun
ONEM 1Life Healthcare
$35.58 /

-0.72 (-1.98%)

ONEM 1Life Healthcare
$35.58 /

-0.72 (-1.98%)

Initiation
Baird starts 'uniquely well-positioned' 1Life Healthcare with an Outperform » 06:50
05/28/21
05/28
06:50
05/28/21
06:50
ONEM

1Life Healthcare

$35.14 /

-0.035 (-0.10%)

As previously reported,…

As previously reported, Baird analyst Vikram Kesavabhotla initiated coverage of 1Life Healthcare with an Outperform rating and $43 price target. The analyst views 1Life as "uniquely well-positioned" to disrupt the primary care market in the U.S. with its "compelling and unique blend" of a retail presence and digital capabilities. While he appreciate ongoing investor concerns about profitability and competition, he expect positive execution in nine new markets coming online to benefit sentiment and valuation, the analyst said.

ShowHide Related Items >><<
ONEM 1Life Healthcare
$35.14 /

-0.035 (-0.10%)

ONEM 1Life Healthcare
$35.14 /

-0.035 (-0.10%)

05/27/21 Baird
1Life Healthcare initiated with an Outperform at Baird
05/21/21
Fly Intel: Top five analyst initiations
05/21/21 KeyBanc
1Life Healthcare initiated with an Overweight at KeyBanc
05/17/21 Credit Suisse
1Life Healthcare price target lowered to $50 from $56 at Credit Suisse
ONEM 1Life Healthcare
$35.14 /

-0.035 (-0.10%)

  • 23
    Nov
  • 25
    Jun
ONEM 1Life Healthcare
$35.14 /

-0.035 (-0.10%)

ONEM 1Life Healthcare
$35.14 /

-0.035 (-0.10%)

Initiation
1Life Healthcare initiated with an Outperform at Baird » 17:44
05/27/21
05/27
17:44
05/27/21
17:44
ONEM

1Life Healthcare

$35.14 /

-0.035 (-0.10%)

Baird analyst Vikram…

Baird analyst Vikram Kesavabhotla initiated coverage of 1Life Healthcare with an Outperform rating and $43 price target.

ShowHide Related Items >><<
ONEM 1Life Healthcare
$35.14 /

-0.035 (-0.10%)

ONEM 1Life Healthcare
$35.14 /

-0.035 (-0.10%)

05/21/21
Fly Intel: Top five analyst initiations
05/21/21 KeyBanc
1Life Healthcare initiated with an Overweight at KeyBanc
05/17/21 Credit Suisse
1Life Healthcare price target lowered to $50 from $56 at Credit Suisse
05/13/21 Canaccord
1Life Healthcare price target lowered to $56 from $64 at Canaccord
ONEM 1Life Healthcare
$35.14 /

-0.035 (-0.10%)

  • 23
    Nov
  • 25
    Jun
ONEM 1Life Healthcare
$35.14 /

-0.035 (-0.10%)

ONEM 1Life Healthcare
$35.14 /

-0.035 (-0.10%)

Hot Stocks
One Medical's model delivers outsized impact in controlling diabetes » 16:13
05/24/21
05/24
16:13
05/24/21
16:13
ONEM

1Life Healthcare

$33.05 /

-0.145 (-0.44%)

Results of a longitudinal…

Results of a longitudinal observational study to be published in JMIR Diabetes demonstrates how One Medical incorporates an embedded diabetes management program within its membered-centered and technology-powered primary care model to deliver better health outcomes for patients, including meaningful reductions in HbA1c, blood glucose, levels. Chronic disease burdens continue to rise, with diabetes and other chronic illnesses among the leading causes of death and disability in America. The CDC estimates that as of 2020, approximately 34 million Americans, just over 10% of the population, had diabetes. Through it's human-centered and technology-powered model, One Medical seeks to address this public health concern by leveraging its multi-modal care strategy. Study Findings The peer-reviewed study is a retrospective observational analysis of a subset of One Medical patients with previously uncontrolled diabetes, and found that a cohort of 621 patients participating in One Medical's diabetes management program saw significant improvements in glucose control and cholesterol levels. Using One Medical's longitudinal primary care model, these patients saw their average HbA1c levels decrease by 19%, from 10.7% to 8.7%. This two point reduction is a significant improvement when compared to similar studies highlighting virtual-only solutions that did not include primary care to manage chronic care, and reported relatively modest improvements of up to 1 point. For context, previous studies have found that a one point reduction in HbA1c is linked to a reduction in risk of death by 21%, heart attacks by 14%, and microvascular complications by 37%. One Medical incorporates chronic care management as an essential part of its member-based and technology-powered primary care services, with key features including the following: Enhanced access to care through same and next-day in-office appointments with primary care providers, as

ShowHide Related Items >><<
ONEM 1Life Healthcare
$33.05 /

-0.145 (-0.44%)

ONEM 1Life Healthcare
$33.05 /

-0.145 (-0.44%)

05/21/21
Fly Intel: Top five analyst initiations
05/21/21 KeyBanc
1Life Healthcare initiated with an Overweight at KeyBanc
05/17/21 Credit Suisse
1Life Healthcare price target lowered to $50 from $56 at Credit Suisse
05/13/21 Canaccord
1Life Healthcare price target lowered to $56 from $64 at Canaccord
ONEM 1Life Healthcare
$33.05 /

-0.145 (-0.44%)

  • 23
    Nov
  • 25
    Jun
ONEM 1Life Healthcare
$33.05 /

-0.145 (-0.44%)

ONEM 1Life Healthcare
$33.05 /

-0.145 (-0.44%)

Initiation
Fly Intel: Top five analyst initiations » 09:52
05/21/21
05/21
09:52
05/21/21
09:52
ONEM

1Life Healthcare

$34.50 /

+0.91 (+2.71%)

, DISH

Dish

$44.53 /

+0.48 (+1.09%)

, OSH

Oak Street Health

$63.50 /

+0.86 (+1.37%)

, AJG

Arthur J. Gallagher

$146.93 /

+0.34 (+0.23%)

, EQX

Equinox Gold

$9.16 /

+0.05 (+0.55%)

Catch up on today's…

Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. 1Life Healthcare (ONEM) initiated with an Overweight at KeyBanc. 2. Dish (DISH) initiated with a Buy at Benchmark. 3. Oak Street Health (OSH) initiated with an Outperform at Bernstein. 4. Arthur J. Gallagher (AJG) initiated with an Underperform at BofA. 5. Equinox Gold (EQX) initiated with a Buy at Desjardins. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

ShowHide Related Items >><<
OSH Oak Street Health
$63.50 /

+0.86 (+1.37%)

ONEM 1Life Healthcare
$34.50 /

+0.91 (+2.71%)

EQX Equinox Gold
$9.16 /

+0.05 (+0.55%)

DISH Dish
$44.53 /

+0.48 (+1.09%)

AJG Arthur J. Gallagher
$146.93 /

+0.34 (+0.23%)

ONEM 1Life Healthcare
$34.50 /

+0.91 (+2.71%)

05/21/21 KeyBanc
1Life Healthcare initiated with an Overweight at KeyBanc
05/17/21 Credit Suisse
1Life Healthcare price target lowered to $50 from $56 at Credit Suisse
05/13/21 Canaccord
1Life Healthcare price target lowered to $56 from $64 at Canaccord
05/13/21 Truist
1Life Healthcare price target lowered to $48 from $56 at Truist
DISH Dish
$44.53 /

+0.48 (+1.09%)

05/21/21 Benchmark
Benchmark starts Dish at Buy, says 5G launch in Las Vegas could be catalyst
05/21/21 Benchmark
Dish initiated with a Buy at Benchmark
05/03/21 Truist
Dish price target raised to $40 from $32 at Truist
05/03/21 Pivotal Research
Dish price target raised to $50 from $34 at Pivotal Research
OSH Oak Street Health
$63.50 /

+0.86 (+1.37%)

05/21/21 Bernstein
Oak Street Health initiated with an Outperform at Bernstein
04/20/21 Cantor Fitzgerald
Oak Street Health initiated with an Overweight at Cantor Fitzgerald
04/20/21 Cantor Fitzgerald
Oak Street Health initiated with an Overweight at Cantor Fitzgerald
03/15/21
Fly Intel: Top five analyst initiations
AJG Arthur J. Gallagher
$146.93 /

+0.34 (+0.23%)

05/21/21 BofA
Arthur J. Gallagher initiated with an Underperform at BofA
05/18/21 Deutsche Bank
Arthur J. Gallagher price target raised to $160 from $145 at Deutsche Bank
05/03/21 Raymond James
Arthur J. Gallagher price target raised to $165 from $155 at Raymond James
04/30/21 Truist
Arthur J. Gallagher price target raised to $165 from $143 at Truist
EQX Equinox Gold
$9.16 /

+0.05 (+0.55%)

05/21/21 Desjardins
Equinox Gold initiated with a Buy at Desjardins
05/20/21 National Bank
Equinox Gold price target raised to C$16.75 from C$15.25 at National Bank
05/06/21 BMO Capital
Equinox Gold price target raised to C$20 from C$18.50 at BMO Capital
05/06/21 TD Securities
Equinox Gold price target lowered to C$18.50 from C$19 at TD Securities
OSH Oak Street Health
$63.50 /

+0.86 (+1.37%)

ONEM 1Life Healthcare
$34.50 /

+0.91 (+2.71%)

DISH Dish
$44.53 /

+0.48 (+1.09%)

AJG Arthur J. Gallagher
$146.93 /

+0.34 (+0.23%)

  • 13
    May
  • 11
    Feb
  • 03
    Dec
  • 23
    Nov
  • 06
    Aug
  • 25
    Jun
ONEM 1Life Healthcare
$34.50 /

+0.91 (+2.71%)

OSH Oak Street Health
$63.50 /

+0.86 (+1.37%)

ONEM 1Life Healthcare
$34.50 /

+0.91 (+2.71%)

DISH Dish
$44.53 /

+0.48 (+1.09%)

AJG Arthur J. Gallagher
$146.93 /

+0.34 (+0.23%)

EQX Equinox Gold
$9.16 /

+0.05 (+0.55%)

DISH Dish
$44.53 /

+0.48 (+1.09%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.